Microplate Systems Market Size is expected to witness commendable growth from 2022 to 2028, on account of the advancement in microplate absorbance reader technology for lab applications, ranging from ELISAs to cell imaging. Moreover, the increased spending in research and development across the pharmaceutical sector will also contribute to the overall industry dynamics over the coming years. Microplates or microtiter plates refer to multi-well plates that can be sealed and used in the fields of pharmaceutics, molecular biology, diagnostics, therapeutics, and biomedical studies. In essence, the system is a glass plate with multiple wells or depressions placed side by side in a rectangular matrix. It has also been gaining widespread usage in cell culture, sample filtration, assays, and nucleic acid and protein quantification.
Rising burden of infectious diseases and the escalating investment in medical research in nations like the United States are among the key factors amplifying microplate systems market trends through 2028. As per a Healthy People 2020 Report, tuberculosis, influenza, and viral hepatitis remain the leading causes of illness and death in the country. Such factors could proliferate industry share, given the usage of microtiter plate readers as an indispensable tool in virology research. The increasing production of varied liquid handlers that allow miniaturized or low volume genotyping reactions along with zero cross-contamination in source wells will also add impetus to industry expansion in the coming years.
Considering the application spectrum, the clinical diagnostics segment will hold a major share in the microplate systems market by 2028. The segment growth is driven by the ability of microplate instrumentation to ensure high efficiency and performance for improved clinical diagnostic workflows. Microplate instruments and software of Agilent BioTek, for example, have been developed for ease of use in operation and setup of ELISA microplate readers, among other uses. In addition, the commendable increase in the number of diagnostic and medical laboratories in the U.S. will further propel the deployment of microplate equipment to boost laboratory workflow.
Asia Pacific microplate systems market will amass substantial profits by 2028, as a result of the high burden of infectious diseases and favorable business landscape for biopharma companies in China, Japan, and other countries. In 2021, Japan-based Bushu Pharmaceuticals Ltd. signed a deal with Suzuken Co. with an aim to offer comprehensive support to specialty pharma manufacturers that are planning to enter the Japanese market. Situations such as these could positively impact the adoption of microplate systems for drug discovery and development activities in the regional pharma sector.
Key industry players include Tecan, Rayto, Promega, PerkinElmer, Mindray, Lonza, Corning, Bmg Labtech, Bio-Rad, Biochrom (Harvard Bioscience), Berthold Technologies, Thermo Fisher Scientific, and Beckman Coulter (Danaher Corporation). These companies are focusing on new product launches and business expansions to increase their footprint in the global market.
For example, in May 2021, Beckman Coulter Life Sciences unveiled a new BioLector XT Microbioreactor, equipped with FlowerPlate microtiter plate technology, designed to enable high-throughput strain screenings, feeding strategy optimization, and cultivation parameter monitoring. In May 2021, Thermo Fisher Scientific launched a range of automated incubators and storage systems, Cytomat 24, for microplate incubation applications.
In the wake of the coronavirus pandemic, the healthcare domain has showcased severe disruptions due to issues regarding supply chain and raw material availability and manufacturing. Several academic, government, and industry research activities related to basic science as well as clinical studies also dwindled amid the pandemic, which may have impacted the microplate systems industry. However, the shifting focus from basic studies to COVID-19-related researches to address the growing demand for medications, diagnostics, and vaccines may create a positive impact on the industry outlook during the forecast timeline.
Market, By Product
Market, By Application
Market, By End-Use
The above information is provided for the following regions and countries: